Skip to main content
SpringerLink
Log in

Risk Factors for and Prevention of Atherosclerotic Cardiovascular Disease

  • Chapter
Cardiology for the primary care Physician

  • 106 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

References and Recommended Reading

  1. Ross R: Atherosclerosis-an inflammatory disease. Review article. Mechanisms of disease. NEngIJMed 1999, 340: 115–126.

    Article  CAS  Google Scholar 

  2. Vokonas PS, Kannel WB, Cupples LA: Epidemiology and risk of hypertension in the elderly: the Framingham Study. JHypertens 1988, 8 (suppl I): 53–59.

    Google Scholar 

  3. SHEP Cooperative Research Group:Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA1991,265:3255–3264.

    Google Scholar 

  4. Mulrow CD, Cornell JA, Herrera CR, et al: Hypertension in the elderly: implications and generalizability of randomized trials. JAMA 1994, 272: 1932–1938.

    Article  PubMed  CAS  Google Scholar 

  5. Castelli WP, Wilson PW, Levy D, Anderson K: Cardiovascular risk factors in the elderly. Am J Cardio11989, 63: 12H - 19H.

    Google Scholar 

  6. Pikkanen J, Linn S, Heiss G, et al.: Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease. NEnglJMed 1990, 322:1700–1707.

    Google Scholar 

  7. Castelli WP, Anderson K, Wilson PWF, et al.: Lipids and risk of coronary heart disease. The Framingham Study. Ann Epidemiol 1992, 2:23–28.

    Google Scholar 

  8. Levine GN, Keaney JF Jr, Vita JA: Cholesterol reduction in cardiovascular disease: clinical benefits and possible mechanisms. NEnglJMed 1995, 332: 512–519.

    Article  CAS  Google Scholar 

  9. Gotto AM Jr: Hypertriglyceridemia: risks and perspectives. Am J Cardiol1992, 70: 19H - 25H.

    Google Scholar 

  10. Shepherd J, Cobbe SM, Ford I, et al.: for the West of Scotland Coronary Prevention Study Group:Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. NEnglJMed 1995, 333:1301–1307.

    Google Scholar 

  11. Downs JR, Clearfield M, Weis I, et al.: Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/Tex CAPS. JAMA 1998, 379:1615–1622.

    Google Scholar 

  12. Scandinavian Simvastatin Survival Study Group: Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994, 344: 1383–1389.

    Google Scholar 

  13. Sacks FM, Pfeffer MA, Moye LA, et al.: for the Cholesterol and Recurrent Events Trial Investigators. The effects of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. NEnglJMed 1996, 335:1001–1009.

    Google Scholar 

  14. The Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) Study Group: Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. NEngl J Med 1998, 339: 1349–1357.

    Article  Google Scholar 

  15. Herbert PR, Gaziano JM, Chan KS, et al.: Cholesterol lowering with statin drugs, risk of stroke, and total mortality: an overview of randomized trials. JAMA 1997, 278:313–321.

    Google Scholar 

  16. Muller JE, Abela GS, Nesto RW, et al.: Triggers, acute risk factors and vulnerable plaques: the lexicon of a new frontier. JAm Coll Cardio11994,23:809–813.

    Google Scholar 

  17. Kannel WB, Higgins M: Smoking and hypertension as predictors of cardiovascular risk in population studies. JHypertens 1990, 8 (suppl 5): S3 - S8.

    CAS  Google Scholar 

  18. Cupples LA, D’Agostino RB: Some risk factors related to the annual incidence of cardiovascular disease and death using pooled repeated biennial measurements: Framingham Heart Study, a 30-year follow-up. In The Framingham Study: An Epidemiological Investigation of Cardiovascular Disease. Edited by Kannel WB, Wolf PA, Garrison RJ: National Heart, Lung and Blood Institute; NIH Publication No. 1987: 87–2703.

    Google Scholar 

  19. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes in the development and progression of long-term complications in insulin-dependent diabetes mellitus. NEnglJMed 1993, 329: 997–986.

    Google Scholar 

  20. Levy D, Salomon M, D’Agostino RB, et al.: Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy. Circulation 1994, 90:1786–1793.

    Google Scholar 

  21. Levy D, Garrison RJ, Savage DD, et al.: Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. NEnglJMed 1990, 322:1561–1566.

    Google Scholar 

  22. Borkan GA, Sparrow D, Wisnieski C, et al.: Body weight and coronary risk: patterns of risk factor change associated with long-term weight change. The Normative Aging Study. Am Epidemio11986,124:410–419.

    Google Scholar 

  23. Manson JE, Colditz GA, Stampfer MJ, et al.: A prospective study of obesity and risk of coronary heart disease in women. NEnglJMed 1990, 322:882–889.

    Google Scholar 

  24. Reaven GM, Lithell H, Landsberg L: Hypertension and associated metabolic abnormalities: the role of insulin resistance and the sympathoadrenal system. NEnglJMed 1996, 334: 374–381.

    Article  CAS  Google Scholar 

  25. Berlin JA, Colditz GA: A meta-analysis of physical activity in the prevention of coronary heart disease. Am JEpidemiol 1990, 132: 612–628.

    Google Scholar 

  26. Paffenbarger RS Jr, Hyde RT, Wing AL, et al.: The association of changes in physical activity level and other lifestyle characteristics with mortality among men. NEnglJMed 1993,328:533–537.

    Google Scholar 

  27. Kannel WB, Anderson K, Wilson PWF: White blood cell count and cardiovascular disease. JAMA 1992, 267: 1253–1256.

    Article  PubMed  CAS  Google Scholar 

  28. Ernst E: Fibrinogen: its emerging role as a cardiovascular risk factor. Angiology 1994, 45: 87–93.

    Article  PubMed  CAS  Google Scholar 

  29. Myers RH, Kiely DK, Cupples LA, et al.: Parental history is an independent risk factor for coronary artery disease: The Framingham Study. Am Heart J 1990,120:963–969.

    Google Scholar 

  30. Chambless LE, Dobson AJ, Patterson CC, et al.: On the use of a logistic risk score in predicting risk of coronary heart disease. Stat Med 1990, 9:385–396.

    Google Scholar 

  31. Wilson PWF, D’Agostino RB, Levy D, et al.: Prediction of coronary heart disease using risk factor categories. Circulation 1998, 97:1837–1847.

    Google Scholar 

  32. Sytkowski PA, Kannel WB, D’Agostino RB: Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study. NEnglJMed 1990, 322: 1635–1641.

    Article  CAS  Google Scholar 

  33. Goldman L: Cost-effectiveness perspectives in coronary heart disease. Am Heart J 1990, 119: 733–739.

    Google Scholar 

Select Bibliography

  1. Fuster V, Pearson TA: Executive summary. Bethesda Conference Report. 27th Bethesda Conference: Matching the intensity of risk factor management with the hazard of coronary disease events. JAm Coll Cardio11996, 27: 961–963.

    Google Scholar 

  2. American Heart Association/American College of Cardiology Consensus Panel Statement on Preventive Cardiology for Women Circulation 1999, 99:2480–2484.

    Google Scholar 

  3. Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure and the National High Blood Pressure Education Program Coordinating Committee. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med 1997, 157: 2413–2446.

    Article  Google Scholar 

  4. Knopp RH: Drug treatment of lipid disorders. Review Article. NEngl JMed 1999, 341: 498–511.

    Article  CAS  Google Scholar 

  5. Pinkney JH, Yudkin JS: Antihypertensive drugs: issues beyond blood pressure control. Prog Cardiovasc Dis 1994, 36: 246–253.

    Article  Google Scholar 

Download references

Authors
  1. Pantel S. Vokonas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. William B. Kannel
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Medicine, University of Arizona, Health Sciences Center, Tucson, Arizona, USA

    Joseph S. Alpert MD (Professor and Chairman, Professor of Medicine, Head) (Professor and Chairman, Professor of Medicine, Head)

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Current Medicine, Inc.

About this chapter

Cite this chapter

Vokonas, P.S., Kannel, W.B. (2001). Risk Factors for and Prevention of Atherosclerotic Cardiovascular Disease. In: Alpert, J.S. (eds) Cardiology for the primary care Physician. Current Medicine Group. https://doi.org/10.1007/978-1-4615-6601-4_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-6601-4_12

  • Publisher Name: Current Medicine Group

  • Print ISBN: 978-1-4615-6603-8

  • Online ISBN: 978-1-4615-6601-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation